Naing, Aung <br/><br/>
A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors.  [electronic resource] 

 -  Investigational new drugs  Feb 2012 
 - 327-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-0646 
<br/><br/><label>Standard No.: </label>10.1007/s10637-010-9536-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Angiogenesis Inhibitors--administration & dosage<br/>Anilides--administration & dosage<br/>Area Under Curve<br/>Biological Availability<br/>Capsules<br/>Chemistry, Pharmaceutical<br/>Cross-Over Studies<br/>Diphosphates--administration & dosage<br/>Drug Compounding<br/>Female<br/>Humans<br/>Least-Squares Analysis<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--administration & dosage<br/>Proto-Oncogene Proteins c-met--antagonists & inhibitors<br/>Quinolines--administration & dosage<br/>Tablets<br/>Treatment Outcome<br/>Young Adult